跳至主要内容
临床试验/ISRCTN17251494
ISRCTN17251494已完成3 期

Stopping Perioperative Angiotensin II Converting Enzyme inhibitors and/or angiotensin receptor blockers in major non-cardiac surgery (SPACE): A phase III, mechanistic, randomised controlled trial

Queen Mary University of London0 个研究点目标入组 260 人开始时间: 2017年5月29日最近更新:

试验速览

阶段
3 期
状态
已完成
入组人数
260

研究概览

简要总结

2023 Results article in https://doi.org/10.1093/eurheartj/ehad716 (added 12/12/2023)

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Informed consent (no incapacitated or vulnerable adult or minors will be included)
  • 2. Currently taking angiotensin converting enzyme inhibitors and/or angiotensin receptor blockers therapy
  • 3. Age 60 years and over
  • 4. Patients undergoing major surgery (major joint replacement/ vascular/ gastrointestinal) requiring general anesthesia that is expected to take longer than 120 minutes
  • 5. American Society of Anesthesiologists grade 3 or above

排除标准

  • 1. Current participation in any other trials
  • 2. Recent myocardial infarction (within 3 months)
  • 3. Any condition, which in the opinion of the treating clinician would result in the patient being harmed by the cessation of the angiotensin II converting enzyme inhibitors and/or angiotensin receptor blockers therapy

研究者

相似试验